MedTrace Logo

Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma

NCT01274325 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2013-09-11

No results posted yet for this study

Summary

The purpose of this study is to test hypothesis if Sereflo (ICS/LABA) could reduce airway inflammation in asthmatic patients in the same as Seretide.

Conditions

Interventions

DRUG

Sereflo

Patients take sereflo (25/125) 2 puffs twice a day for 4 weeks

DRUG

Seretide

Patients will take Seretide (25/125) 2 puffs twice a day for 4 weeks

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Kittipong Maneechotesuwan, MD., PhD. · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-04-30
Completion
2013-07-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01274325 on ClinicalTrials.gov